시장보고서
상품코드
1483115

핵산 분리 및 정제 시장 평가 : 제품별, 유형별, 방법별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Nucleic Acid Isolation and Purification Market Assessment, By Product, By Type, By Method, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 233 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 핵산 분리 및 정제 시장 규모는 2024-2031년 예측 기간 동안 8.06%의 CAGR로 2023년 48억 9,000만 달러에서 2031년 91억 달러로 성장할 것으로 예상됩니다. 헬스케어 분야의 확대, 유전성 질환의 부담 증가, 핵산 분리 및 정제 기술 발전, 분자진단에 대한 수요 증가가 이 시장의 성장을 뒷받침하고 있습니다.

세계 여러 지역에서 암을 포함한 다양한 유전성 질환의 부담이 증가하고 있는 것은 세계 핵산 분리 및 정제 시장의 주요 트렌드 중 하나입니다. 미국 국립 암 연구소의 추정에 따르면 2022년에는 전 세계적으로 약 2,000만 건의 새로운 암 사례가 보고되었으며, 2040년까지 이 숫자는 2,990만 건으로 증가할 것으로 예상됩니다. 이러한 증가는 연구자들이 이러한 질병에 대한 인사이트를 얻는 데 도움이되기 때문에 연구 기관에서 핵산 분리 및 정제 장비 및 키트에 대한 수요를 촉진하고 있습니다. 연구는 이러한 질병의 유전적 메커니즘을 더 잘 이해하여 새로운 개입, 조기 진단 테스트 및 새로운 치료법을 개발할 수 있도록 돕습니다.

자동 핵산 분리 및 정제 시스템 개발을 포함한 기술 발전으로 인해 전 세계 핵산 분리 및 정제 시장 규모가 확대되고 있습니다. 고순도 시료를 처리하는 동시에 처리량, 정확도, 재현성 향상에 대한 요구가 높아지면서 이러한 장비 개발에 대한 노력이 활발해지고 있습니다.

이 보고서는 세계 핵산 분리 및 정제 시장을 조사하여 시장 개요와 함께 제품 유형별, 방법별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 세계의 핵산 분리와 정제 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 제품별
  • 유형별
  • 방법별
  • 용도별
  • 최종사용자별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제5장 세계의 핵산 분리와 정제 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제6장 시장 매핑, 2023년

제7장 거시적 환경과 산업 구조

  • 공급 수요 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 프레임워크와 혁신

제10장 주요 진출 기업 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 진출 기업 전망

  • QIAGEN N.V
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE HealthCare Technologies, Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Promega Corporation
  • Takara Bio, Inc.

제14장 전략적 제안

제15장 문의와 면책사항

ksm 24.05.31

Global nucleic acid isolation and purification market is projected to witness a CAGR of 8.06% during the forecast period 2024-2031F, growing from USD 4.89 billion in 2023 to USD 9.1 billion in 2031F. The growth of the market is supported by the expansion of healthcare sector, increasing burden of genetic diseases, technological advancements in nucleic acid isolation and purification, and rising requirement from molecular diagnostics.

The increasing burden of various genetic diseases, including cancer, in various regions across the globe is one of the major global nucleic acid isolation and purification market trends. According to the estimates of the National Cancer Institute, in 2022, approximately 20 million new cases of cancer were reported across the globe. By 2040, the number is expected to increase to 29.9 million. The rise is propelling the requirement for nucleic acid isolation and purification instruments and kits from research institutes as studying nucleic acids helps researchers gain insights into such diseases. The research aids in improving the understanding of genetic mechanisms behind such conditions, enabling the development of novel interventions, early diagnostic tests, and new treatments.

Advancements in technology, including the development of automated nucleic acid isolation and purification systems, are bolstering the global nucleic acid isolation and purification market size. Rising efforts to develop such devices can be attributed to the growing requirement for increased throughput, accuracy, and reproducibility while processing samples with a high degree of purity.

Various companies are investing towards the development of modular instruments that are capable of working together with the help of connected software for addressing complete workflows including, extraction, sample preparation, and downstream preparation of nucleic acids that have been purified for several applications. The isolation of high-quality nucleic acids is essential for various downstream applications including genetic engineering, life sciences, forensics, diagnostics, and sequencing.

Expansion of Molecular Diagnostics Sector Boosts Market Demand

The rising requirement for molecular diagnostics is boosting the global demand for nucleic acid isolation and purification. The growing requirement of molecular diagnostics can be attributed to their increasing utilization in guiding patient management, treatment, and diagnosis, particularly in the arena of congenital abnormalities, cancer, and infectious diseases. The rising requirement for molecular diagnostics is supported by the increasing awareness about the benefits offered by personalized medicines and growing prevalence of chronic diseases.

According to the estimates of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six out of ten Americans live with at least one chronic health condition. Molecular diagnostics is essential for improving the treatment and diagnosis of a broad range of diseases, resulting in better patient outcomes. Thus, the growing requirement for molecular diagnostics will propel the demand for nucleic acid isolation and purification kits and instruments.

Increasing Emphasis on Research and Development Activities

The rising investments by various organizations towards research and development activities are providing lucrative growth opportunities to the market. Such activities allow the development of novel technologies that support the expansion of the market. For instance, in February 2023, BioEcho Life Sciences announced they had received two new patents from the Japan Patent Office and the United States Patent and Trademark Office. The patent called "Rapid purification of high-quality nucleic acids from biological samples" will aid the company in strengthening its intellectual property portfolio. The EchoLUTION technology developed by the company supports DNA and RNA extraction in a single centrifugation step. The patent strengthens the company's position as a transformation driver for various processes in biopharmaceutical research, academics, and molecular diagnostics. Such developments are expected to support the expansion of the market in the coming years.

North America Accounts for a Significant Market Share

The expansion of the market in North America is supported by the increasing investments by the government and research institutes towards molecular biology and genomics, rapid growth of the pharmaceutical and biotechnology sectors in the region, and strong presence of various market players. The consistent research and development efforts coupled with the presence of a favorable regulatory framework is boosting the growth of North America nucleic acid isolation and purification market. The increasing investments in biotechnology sector is expected to boost the requirement for nucleic acid isolation and purification kits and instruments in the coming years. In 2023, the biotech firms in the United States attracted a total funding of USD 56.79 billion. The rising requirement for personalized medicines due to the rapid expansion of the healthcare sector is another major factor augmenting the growth of the market in the region.

DNA Isolation and Purification Expected to Witness Significant Growth

The expansion of the segment can be attributed to the importance of DNA extraction in studying the different genetic causes associated with a disease. It is important for developing diagnostics and drugs, carrying out sequencing genomes, and detecting viruses and bacteria, among others. The introduction of novel products by various leading market players is another major factor supporting the expansion of the segment. In May 2024, One BioMed launched X8 HMW DNA Cartridge Kits. The kits are capable of extracting high molecular weight (HMW) DNA in an automated manner, for usage in genome assembly and long-read sequencing. The kit is the world's first automated platform to extract high molecular weight DNA from various sample types such as cell culture, peripheral blood mononuclear cells, bacteria, etc. The company's patented Xceler8 technology is expected to redefine nucleic acid extraction by utilizing a rapid and gentle chemistry-based approach for selectively binding, clustering, and purifying intact DNA with the help of controlled fluidics.

Hospitals and Diagnostic Centers Hold Significant Market Share

The rising requirement for nucleic acid isolation and purification instruments and kits from the hospitals and diagnostic centers can be attributed to the growing prevalence of various genetic diseases and disorders across the globe. According to the estimates of the National Health, Lung, and Blood Institute, in a year, sickle cell amenia affects approximately 20 million individuals across the globe. Hospitals and diagnostic centers are heavily investing in advanced and innovative diagnostic equipment to enhance the care and services provided to the patients. RNA and DNA purification and isolation techniques are some of the efficient techniques that are deployed for diagnosing various genetic diseases inducing cystic fibrosis, sickle cell anemia, down's syndrome, and others. Furthermore, the growing emergence of new diagnostic assays and rising requirement for point-of-care testing is augmenting the demand for nucleic acid isolation and purification processes that can be easily incorporated with the diagnostic workflow, providing lucrative growth opportunities to the market.

Future Market Scenario (2024 - 2031F)

According to nucleic acid isolation and purification market analysis, the market is expected to witness significant growth in the coming years due to the increasing popularity of nucleic acid-based diagnostics and the rapid expansion of the pipeline for RNA therapeutics. The increasing utilization of sequencing platforms for clinical diagnostics and rising research and development activities will further expand the market. The growing number of genetic and infectious diseases is expected to boost the demand for nucleic acid isolation and purification instruments and kits for diagnostic applications.

Key Players Landscape and Outlook

The major players in the nucleic acid isolation and purification market are QIAGEN N.V., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Danaher Corporation. The introduction of novel instruments and technologies by leading market players is expected to provide lucrative growth opportunities for the market. In December 2023, Thermo Fisher Scientific Inc. launched an automated nucleic acid purification instrument called Thermo Scientific KingFisher Apex Dx. The product is expected to provide laboratories with in vitro diagnostic regulation approved sample prepared solutions for boosting the confidence in downstream results. The system automates the extraction of RNA, DNA, protein, and cell samples by offering IVD and RUO software modes.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nucleic Acid Isolation and Purification Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Instruments
      • 4.2.1.1.Manual
      • 4.2.1.2.Automatic
    • 4.2.2.Kits and Reagents
  • 4.3.By Type
    • 4.3.1.RNA Isolation and Purification
      • 4.3.1.1.mRNA Isolation and Purification
      • 4.3.1.2.miRNA Isolation and Purification
      • 4.3.1.3.Total RNA Isolation and Purification
      • 4.3.1.4.Others
    • 4.3.2.DNA Isolation and Purification
      • 4.3.2.1.Genomic DNA Isolation and Purification
      • 4.3.2.2.Viral DNA Isolation and Purification
      • 4.3.2.3.Plasmid DNA Isolation and Purification
      • 4.3.2.4.Others
  • 4.4.By Method
    • 4.4.1.Column-based
    • 4.4.2.Reagent-based
    • 4.4.3.Magnetic Beads
    • 4.4.4.Others
  • 4.5.By Applications
    • 4.5.1.Diagnostics
    • 4.5.2.Precision Medicine
    • 4.5.3.Drug Discovery and Development
    • 4.5.4.Agriculture and Animal Research
    • 4.5.5.Others
  • 4.6.By End-users
    • 4.6.1.Academic and Research Institutes
    • 4.6.2.Hospitals and Diagnostic Centers
    • 4.6.3.Contract Research Organizations
    • 4.6.4.Pharmaceutical and Biotechnology Companies
    • 4.6.5.Others
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.South America
    • 4.7.3.Europe
    • 4.7.4.Asia-Pacific
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Nucleic Acid Isolation and Purification Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Instruments
        • 5.1.2.1.1.Manual
        • 5.1.2.1.2.Automatic
      • 5.1.2.2.Kits and Reagents
    • 5.1.3.By Type
      • 5.1.3.1.RNA Isolation and Purification
        • 5.1.3.1.1.mRNA Isolation and Purification
        • 5.1.3.1.2.miRNA Isolation and Purification
        • 5.1.3.1.3.Total RNA Isolation and Purification
        • 5.1.3.1.4.Others
      • 5.1.3.2.DNA Isolation and Purification
        • 5.1.3.2.1.Genomic DNA Isolation and Purification
        • 5.1.3.2.2.Viral DNA Isolation and Purification
        • 5.1.3.2.3.Plasmid DNA Isolation and Purification
        • 5.1.3.2.4.Others
    • 5.1.4.By Method
      • 5.1.4.1.Column-based
      • 5.1.4.2.Reagent-based
      • 5.1.4.3.Magnetic Beads
      • 5.1.4.4.Others
    • 5.1.5.By Applications
      • 5.1.5.1.Diagnostics
      • 5.1.5.2.Precision Medicine
      • 5.1.5.3.Drug Discovery and Development
      • 5.1.5.4.Agriculture and Animal Research
      • 5.1.5.5.Others
    • 5.1.6.By End-users
      • 5.1.6.1.Academic and Research Institutes
      • 5.1.6.2.Hospitals and Diagnostic Centers
      • 5.1.6.3.Contract Research Organizations
      • 5.1.6.4.Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.Others
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
        • 5.1.7.1.2.By Volume
      • 5.1.7.2.By Product
        • 5.1.7.2.1.Instruments
          • 5.1.7.2.1.1.Manual
          • 5.1.7.2.1.2.Automatic
        • 5.1.7.2.2.Kits and Reagents
      • 5.1.7.3.By Type
        • 5.1.7.3.1.RNA Isolation and Purification
          • 5.1.7.3.1.1.mRNA Isolation and Purification
          • 5.1.7.3.1.2.miRNA Isolation and Purification
          • 5.1.7.3.1.3.Total RNA Isolation and Purification
          • 5.1.7.3.1.4.Others
        • 5.1.7.3.2.DNA Isolation and Purification
          • 5.1.7.3.2.1.Genomic DNA Isolation and Purification
          • 5.1.7.3.2.2.Viral DNA Isolation and Purification
          • 5.1.7.3.2.3.Plasmid DNA Isolation and Purification
          • 5.1.7.3.2.4.Others
      • 5.1.7.4.By Method
        • 5.1.7.4.1.Column-based
        • 5.1.7.4.2.Reagent-based
        • 5.1.7.4.3.Magnetic Beads
        • 5.1.7.4.4.Others
      • 5.1.7.5.By Applications
        • 5.1.7.5.1.Diagnostics
        • 5.1.7.5.2.Precision Medicine
        • 5.1.7.5.3.Drug Discovery and Development
        • 5.1.7.5.4.Agriculture and Animal Research
        • 5.1.7.5.5.Others
      • 5.1.7.6.By End-users
        • 5.1.7.6.1.Academic and Research Institutes
        • 5.1.7.6.2.Hospitals and Diagnostic Centers
        • 5.1.7.6.3.Contract Research Organizations
        • 5.1.7.6.4.Pharmaceutical and Biotechnology Companies
        • 5.1.7.6.5.Others
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Type
  • 6.3.By Method
  • 6.4.By Applications
  • 6.5.By End-users
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.QIAGEN N.V.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Agilent Technologies, Inc.
  • 13.3.Thermo Fisher Scientific Inc.
  • 13.4.Bio-Rad Laboratories, Inc.
  • 13.5.Danaher Corporation
  • 13.6.GE HealthCare Technologies, Inc.
  • 13.7.Merck KGaA
  • 13.8.F. Hoffmann-La Roche Ltd
  • 13.9.Promega Corporation
  • 13.10.Takara Bio, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제